Professional stock pickers in the mutual-fund industry had a tough time in 2024 beating indexes that passively track U.S.

BofA analyst Alec Stranahan lowered the firm’s price target on Regenxbio (RGNX) to $22 from $25 and keeps a Buy rating on the ...

Stock investors may start shunning favorable economic data, Bank of America said ahead of Friday’s release of the December ...

The U.S. stock market is back to an uncomfortably familiar spot, with Wall Street no longer celebrating good news on the ...

Ebrahim Poonawala, Bank of America managing director, joins 'Closing Bell Overtime' to talk changes in the Federal Reserve ...

"Tariffs raise two main concerns," BofA notes. They explain that first is the potential negative impact on global growth and ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

Tesla (TSLA) shares are under pressure after Bank of America analysts downgraded the stock to Neutral from Buy, citing ...

BofA Securities analyst John Murphy downgraded Tesla to Hold from Buy, citing that much of Tesla’s growth potential, ...

International benchmark Brent crude will average $65 a barrel this year as new oil production from non-OPEC countries ...

Texas and other GOP-led states have taken aim at Wall Street for practices they view as hostile to fossil fuels, and ...

The U.S.’s oldest bank beat Bank of America to a $25-per-hour pay floor – and is touting its rank-and-file stock offerings ...